Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 381,147 | 441,445 | 451,822 | 403,645 | 570,797 |
| Marketable Securities | 558,618 | 482,354 | 439,504 | 595,092 | 306,050 |
| Receivables | 162,588 | 162,896 | 166,388 | 117,095 | 123,192 |
| Inventories | 117,885 | 113,421 | 115,285 | 126,707 | 131,037 |
| Other current assets | 70,538 | 57,084 | 48,409 | 44,805 | 53,972 |
| TOTAL | $1,290,776 | $1,257,200 | $1,221,408 | $1,287,344 | $1,185,048 |
| Non-Current Assets | |||||
| PPE Net | 0 | 0 | 0 | 264,012 | 0 |
| TOTAL | $0 | $0 | $0 | $264,012 | $0 |
| Total Assets | $3,546,723 | $3,584,759 | $3,552,092 | $3,165,689 | $3,128,473 |
| Liabilities | |||||
| Current Liabilities | |||||
| TOTAL | $183,251 | $155,673 | $152,541 | $125,693 | $139,043 |
| Non-Current Liabilities | |||||
| Long Term Debt | 36,098 | 51,866 | 52,799 | 32,069 | 32,002 |
| TOTAL | $36,098 | $51,866 | $52,799 | $32,069 | $32,002 |
| Total Liabilities | $1,696,366 | $1,692,336 | $1,697,959 | $1,358,842 | $1,374,536 |
| Shareholders' Equity | |||||
| Retained earnings | -26,133 | -54,296 | -73,985 | -84,494 | -97,083 |
| Other shareholders' equity | 1,876,490 | 1,946,719 | 1,928,118 | 1,891,341 | 1,851,020 |
| TOTAL | $1,850,357 | $1,892,423 | $1,854,133 | $1,806,847 | $1,753,937 |
| Total Liabilities And Equity | $3,546,723 | $3,584,759 | $3,552,092 | $3,165,689 | $3,128,473 |